4.8 Article

Pten haploinsufficiency accelerates formation of high-grade astrocytomas

Journal

CANCER RESEARCH
Volume 68, Issue 9, Pages 3286-3294

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-07-6867

Keywords

-

Categories

Funding

  1. NCI NIH HHS [U24 CA126608, U24CA126608, U24 CA126608-01] Funding Source: Medline
  2. NCRR NIH HHS [P41-RR02584, P41 RR002584] Funding Source: Medline
  3. NINDS NIH HHS [R37 NS033199, R37 NS033199-10, P50 NS052606-05, R37NS33199, P50 NS052606] Funding Source: Medline

Ask authors/readers for more resources

We previously reported that central nervous system (CNS) inactivation of Nf1 and p53 tumor suppressor genes in mice results in the development of low-grade to high-grade progressive astrocytomas. When the tumors achieve high grade, they are frequently accompanied by Akt activation, reminiscent of the frequent association of PTEN mutations in human high-grade glioma. In the present study, we introduced CNS heterozygosity of Pten into the Nf1/p53 astrocytoma model. Resulting mice had accelerated morbidity, shortened survival, and full penetrance of high-grade astrocytomas. Haploinsufficiency of Pten accelerated formation of grade 3 astrocytomas, whereas loss of Pten heterozygosity and Akt activation coincided with progression into grade 4 tumors. These data suggest that successive loss of each Pten allele may contribute to de novo formation of high-grade astrocytoma and progression into glioblastoma, respectively, thus providing insight into the etiology of primary glioblastoma. The presence of ectopically migrating neural stem/progenitor lineage cells in presymptomatic Pten-deficient mutant brains supports the notion that these tumors may arise from stem/progenitor cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available